dr. rugo discusses late recurrence in hr breast cancer
Published 6 years ago • 379 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
2:11
dr. rugo discusses monarch i in hr her2- breast cancer
-
2:27
dr. holmes discusses late recurrence and the ma.17 trial in breast cancer
-
1:52
dr. rugo on swish trial for hr-positive breast cancer
-
1:15
dr. rugo discusses the future of angiogenesis in breast cancer
-
0:52
dr. rugo discusses guidelines for metastatic breast cancer management
-
1:20
dr. rugo on hormone therapy for patients with breast cancer
-
1:05
dr rugo on managing treatment-limiting toxicities in breast cancer
-
1:55
dr. rugo on pathway blockade in breast cancer
-
1:05
dr. rugo on ongoing trials in her2 breast cancer
-
1:26
dr. rugo on rationale for the elaine study in esr1-mutated er /her2- breast cancer
-
1:23
brock schroeder discusses bci findings in er breast cancer
-
1:42
dr. rugo on chemotherapy for metastatic breast cancer
-
3:04
dr. rugo on 20-year span of breast cancer advancements
-
1:36
dr. rugo on the efficacy of bevacizumab in breast cancer
-
1:57
dr. rugo on results of oral paclitaxel with encequidar in metastatic breast cancer
-
0:52
dr. graff on genomic risk prediction in hr /her2- breast cancer
-
2:13
n9831 trial: genes associated with early and late recurrence in her2 breast cancer
-
1:46
ctdna and late recurrence in high-risk, hr , her2- breast cancer
-
2:35
dr. rugo on the phase iii sophia trial in her2 breast cancer